Oral Glucose Tolerance Test (OGTT): How Nutrition and Fasting Change Your Results

What the OGTT Actually Tests, and Why It Matters More Than Fasting Glucose Alone

The OGTT captures something a fasting glucose cannot: how efficiently your pancreatic beta cells release insulin and how quickly your peripheral tissues clear a real glucose load. Fasting glucose reflects your overnight steady state. The two-hour post-load value reveals the dynamic response.

For women, that dynamic response is shaped by sex hormones at every life stage. Estrogen generally improves insulin sensitivity at the receptor level, while progesterone in the luteal phase blunts it. During pregnancy, placental hormones drive a physiological state of insulin resistance that peaks in the third trimester, which is exactly why gestational diabetes mellitus (GDM) screening is timed at 24 to 28 weeks. In perimenopause, the loss of regular estrogen pulses coincides with a measurable rise in post-load glucose even when fasting numbers look fine.

A 2021 analysis published in Diabetes Care found that women with normal fasting glucose had a significantly higher prevalence of isolated post-challenge hyperglycemia than men in the same cohort, confirming that relying on fasting glucose alone systematically under-diagnoses glucose dysregulation in women.

How the OGTT Is Performed

1. You follow a carbohydrate-adequate diet (minimum 150 g/day) for at least three days before the test.
2. You fast for 8 to 14 hours overnight, water only.
3. A fasting blood sample is drawn.
4. You drink a standardized 75 g glucose solution within 5 minutes.
5. Blood is drawn at exactly 1 hour and 2 hours (or at 1 hour only for GDM screening protocols that use a single post-load time point).

The test is done seated. You do not walk around, eat, drink anything other than water, or smoke during the two-hour window because any of those variables alters glucose kinetics.

Why Timing Precision Matters

Blood draws outside the specified windows produce unreliable numbers. A draw at 115 minutes instead of 120 minutes can miss a post-load peak that was already descending. If your phlebotomist is running late, ask them to document the actual draw time so your clinician can interpret the result in context.

Normal Ranges, Prediabetes Cutoffs, and Optimal Values

The diagnostic cutoffs below come from the American Diabetes Association 2024 Standards of Care and ACOG Practice Bulletin 190.

Non-Pregnant Adults

| Result | 2-Hour Glucose (mg/dL) | 2-Hour Glucose (mmol/L) | |---|---|---| | Normal | <140 | <7.8 | | Prediabetes (impaired glucose tolerance) | 140 to 199 | 7.8 to 11.0 | | Diabetes | ≥200 | ≥11.1 |

A fasting value ≥126 mg/dL on the same draw independently meets the diabetes diagnosis threshold.

What "Optimal" Means Beyond "Normal"

Longevity-medicine practitioners and some endocrinologists argue that a two-hour value below 120 mg/dL (6.7 mmol/L) is more protective for long-term metabolic health than simply clearing the 140 mg/dL threshold. The Whitehall II study tracked 6,538 civil servants over 11 years and found that cardiovascular risk began rising continuously above approximately 110 mg/dL at two hours, well before the clinical prediabetes cutoff. For women specifically, insulin resistance compounds atherosclerotic risk through inflammatory pathways that differ from men. If you are aiming for genuinely low metabolic risk, a two-hour value in the 90 to 119 mg/dL range is a reasonable target, not merely sub-140.

This "optimal versus normal" distinction is especially relevant for women with PCOS, a family history of type 2 diabetes, or a personal history of GDM, all groups whose lifetime risk of progressing from impaired glucose tolerance to frank diabetes is substantially higher than the general population.

Gestational Diabetes Cutoffs

ACOG Practice Bulletin 190 endorses two approaches for the 75 g OGTT in pregnancy:

• Fasting ≥92 mg/dL, OR
• 1-hour ≥180 mg/dL, OR
• 2-hour ≥153 mg/dL

Any single abnormal value on this three-point screen meets the GDM diagnosis under the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, which ACOG adopted. One abnormal value is sufficient because placental glucose transfer means even mild maternal hyperglycemia harms fetal outcomes.

How Nutrition in the Three Days Before the Test Changes Your Results

This is the rule most women are not told clearly: if you have been eating a low-carbohydrate diet, doing prolonged fasting, or restricting calories in the week before an OGTT, your test result will be falsely elevated, possibly enough to generate a false-positive GDM or prediabetes diagnosis.

The Physiology of Carbohydrate Restriction and False Highs

When you eat fewer than roughly 100 to 150 g of carbohydrate per day for several days, your muscle and liver cells downregulate the glucose transporters (GLUT4) and insulin receptor signaling needed to quickly clear a glucose load. The pancreas still secretes insulin, but peripheral uptake is blunted. The result is a two-hour glucose that overshoots the normal range despite the fact that your actual day-to-day glucose metabolism may be perfectly healthy. This effect is sometimes called "physiological insulin resistance" or "starvation diabetes" in older literature.

The ADA Standards of Care explicitly require at least 150 g of carbohydrate per day for three days before the OGTT for this reason. If your diet is typically ketogenic or very low carbohydrate and your clinician orders an OGTT, discuss whether a formal three-day carbohydrate loading protocol is appropriate, or whether continuous glucose monitoring might offer a more ecologically valid picture of your real glucose patterns.

What to Eat in the Three Days Before

You do not need to binge on refined carbohydrates. The goal is reaching 150 to 200 g of carbohydrate daily from whole-food sources:

• One cup of cooked oats plus one medium banana at breakfast covers roughly 70 g.
• A sandwich on whole-grain bread with a piece of fruit at lunch adds another 60 g.
• A dinner of one cup of cooked rice or pasta with vegetables and protein completes the target.

Dietary fat and protein intake do not need to change. Alcohol should be avoided for at least 24 hours before the test because it impairs hepatic gluconeogenesis and can falsely lower fasting glucose.

The Night Before and Morning of the Test

Fast for 8 to 14 hours. Water is allowed and encouraged because dehydration slows gastric emptying, which can alter the timing of glucose absorption and shift peak values. Avoid vigorous exercise the evening before and on the morning of the test. A 2009 study in the European Journal of Applied Physiology found that intense exercise in the 24 hours before an OGTT measurably lowered two-hour glucose through increased GLUT4 expression, which could mask impaired glucose tolerance in an athlete who trains hard the day before the test.

Light walking to the clinic is fine. A high-intensity spin class at 6 a.m. Before a 7 a.m. Draw is not.

How Your Hormonal Status and Life Stage Affect OGTT Results

Reproductive Years: Menstrual Cycle Phase

Insulin sensitivity fluctuates across the menstrual cycle. In the follicular phase (days 1 to 14), estrogen primes insulin receptor sensitivity. In the luteal phase (days 15 to 28), rising progesterone reduces peripheral glucose uptake. A study in Fertility and Sterility comparing OGTT results in healthy women across cycle phases found that two-hour glucose values were significantly higher in the mid-luteal phase than in the follicular phase, by approximately 10 to 15 mg/dL, even with identical prep.

This has a real-world implication: if your OGTT is borderline and was drawn in the luteal phase, your clinician should consider repeating it in the follicular phase before confirming a prediabetes diagnosis. This recommendation is not yet standard in most guidelines, which is an evidence gap worth flagging.

PCOS: Why OGTT Is Preferred Over Fasting Glucose

Women with PCOS have a prevalence of impaired glucose tolerance roughly three times higher than age- and weight-matched controls without PCOS. The mechanism involves both insulin receptor post-binding defects unique to PCOS and the additive effect of androgens on adipose tissue insulin resistance.

Critically, women with PCOS frequently have normal fasting glucose while showing frank impaired glucose tolerance at two hours. The Endocrine Society 2023 PCOS Clinical Practice Guideline recommends OGTT, not fasting glucose or HbA1c alone, for glucose screening in PCOS because HbA1c misses a substantial fraction of cases. For women with PCOS, the OGTT is the right test.

Perimenopause and Menopause

The menopausal transition brings declining estrogen, redistributed adiposity toward the abdomen, and measurably worsening insulin sensitivity. A longitudinal analysis from the Study of Women's Health Across the Nation (SWAN) found that insulin resistance, measured by HOMA-IR, increased significantly across the menopausal transition independent of age and body weight changes.

Post-load glucose values that were comfortably normal at 40 may creep into the high-normal or prediabetes range by 52 without any change in diet or activity. The OGTT is more sensitive to this shift than fasting glucose or HbA1c. Perimenopausal women who have a family history of type 2 diabetes, had GDM in a prior pregnancy, or carry excess visceral fat are candidates for periodic OGTT screening, even if their fasting glucose and HbA1c remain reassuringly normal.

Hormone therapy (HT) with estrogen may improve insulin sensitivity and modestly lower two-hour post-load glucose. The Women's Health Initiative Observational Study found that women using oral combined HT had a 35% lower incidence of type 2 diabetes compared with non-users, though causality and the effect of route of administration require nuance that is beyond the scope of this article.

Pregnancy: GDM Screening at 24 to 28 Weeks

Screening for gestational diabetes is one of the most important uses of the OGTT. ACOG recommends universal GDM screening at 24 to 28 weeks of gestation, or at the first prenatal visit for women with risk factors (pre-pregnancy BMI ≥30, prior GDM, first-degree relative with type 2 diabetes, or prior macrosomic infant).

GDM affects approximately 6 to 9% of pregnancies in the United States and carries risks that extend beyond delivery: women with a history of GDM have a 7- to 10-fold higher lifetime risk of developing type 2 diabetes. Postpartum retesting at 4 to 12 weeks with a 75 g OGTT is therefore recommended by ACOG for all women who had GDM, yet adherence to this follow-up test remains poor.

Nausea in early pregnancy can make the glucose drink difficult to tolerate. If vomiting occurs during the test, the result is invalid and the test must be repeated on a different day.

Factors That Can Falsely Raise or Lower Your OGTT Result

Understanding confounders helps you and your clinician interpret borderline results rather than reacting to a single number.

Factors That May Falsely Raise 2-Hour Glucose

• Carbohydrate restriction or very low-calorie dieting in the prior week (most common cause of false-positive results)
• Acute illness, infection, or recent surgery (stress hormones drive hepatic glucose output)
• Corticosteroid use (prednisone, dexamethasone)
• Luteal-phase testing in women with cycle-dependent insulin resistance
• Sitting completely still during the two-hour window if you are normally highly active (mild muscular glucose uptake is suspended)
• Delayed gastric emptying (gastroparesis or high dietary fat the night before slows glucose absorption, shifting the peak)

Factors That May Falsely Lower 2-Hour Glucose

• Intense exercise in the 12 to 24 hours before the test (upregulates GLUT4)
• Metformin, GLP-1 receptor agonists, or SGLT2 inhibitors taken the morning of the test (discuss with your clinician whether to hold these)
• Rapid gastric emptying (post-bariatric surgery patients often have a biphasic curve with reactive hypoglycemia rather than hyperglycemia)

Who Should Have an OGTT (and Who Can Use HbA1c Instead)

The OGTT is not the right test for every clinical question. Here is a practical framework by life stage and indication.

Situations Where OGTT Is the Preferred Test

• GDM screening in pregnancy (HbA1c is not validated for pregnancy screening)
• PCOS with normal fasting glucose (the Endocrine Society guideline recommends OGTT here)
• Borderline or discordant fasting glucose and HbA1c (one is elevated, the other is not)
• Postpartum diabetes screening after GDM (6 to 12 weeks postpartum; HbA1c may be falsely low due to postpartum erythropoiesis)
• Evaluation of reactive hypoglycemia (a 5-hour OGTT can capture late hypoglycemic dips)
• Research or longevity screening where the most sensitive early-detection measure is needed

Situations Where HbA1c May Be Sufficient

• Routine annual metabolic screening in non-pregnant women without PCOS and with no specific risk factors
• Monitoring of known type 2 diabetes (though OGTT is not used for monitoring, only for diagnosis)
• Women with hemoglobin variants or hemolytic anemia should avoid HbA1c because it is unreliable in those conditions; OGTT or fructosamine is preferred

Pregnancy and Lactation Considerations

This section applies specifically to the OGTT as a diagnostic procedure rather than a drug. There is no pharmacological agent in the test solution beyond glucose, which is endogenous. The 75 g glucose drink carries no fetal harm at the diagnostic dose. Women with suspected or known type 1 diabetes require closer monitoring during the fasting period and the post-load window to avoid symptomatic hypoglycemia.

Postpartum retesting is mandatory and often missed. ACOG recommends a 75 g OGTT at 4 to 12 weeks postpartum for all women diagnosed with GDM, yet fewer than 20% of eligible women complete this test. During breastfeeding, the test is safe. Fasting may affect milk supply in some women, so feeding or pumping before leaving for the appointment and bringing a snack to eat immediately after the blood draws are complete are practical strategies.

Women found to have prediabetes on postpartum testing should be retested every one to three years given their elevated conversion risk. Metformin and lifestyle intervention both reduce progression from prediabetes to type 2 diabetes, and the decision to start pharmacotherapy during lactation should be made jointly with a clinician. LactMed notes that metformin transfers into breast milk at low concentrations and is generally considered compatible with breastfeeding by most lactation specialists.

Making Sense of a Borderline Result

A single borderline OGTT result, say a two-hour value of 148 mg/dL, does not automatically mean you have prediabetes. Before your clinician confirms that diagnosis, consider asking the following questions together:

1. Was the three-day carbohydrate preparation followed exactly?
2. Was the test drawn in the luteal phase? If so, would a repeat in the follicular phase be reasonable?
3. Was there an acute stressor, illness, or unusual cortisol load in the prior week?
4. Were any medications taken that morning that could affect glucose?

The ADA 2024 Standards of Care state that a prediabetes diagnosis based on a single OGTT result should be confirmed with a repeat test on a different day unless the value is substantially elevated. A confirmatory test also catches true prediabetes that might have been missed on a single occasion.

"The oral glucose tolerance test remains the most sensitive tool for detecting glucose dysregulation in women, particularly in pregnancy and in conditions like PCOS where fasting measures routinely underestimate the problem," according to guidance from the Endocrine Society's 2023 PCOS Clinical Practice Guideline.

A clinician reviewing your full clinical picture, your cycle phase, your recent diet, your medication list, and your family history can turn a borderline number into an actionable plan rather than an anxiety-provoking label. Ask for that full-picture conversation before accepting a diagnosis that will follow you in your medical record for years.

If your two-hour OGTT comes back at 140 mg/dL or higher on a properly prepared, properly timed test, the next step is a structured lifestyle intervention: a minimum of 150 minutes of moderate-intensity activity per week and a dietary pattern emphasizing fiber, protein, and slower-digesting carbohydrates, which the Diabetes Prevention Program trial showed reduces progression from impaired glucose tolerance to type 2 diabetes by 58% over three years.